<description>&lt;div&gt;The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo. &lt;/div&gt; </description>

Stock Day Media

Stock Day Media

Ensysce Biosciences Discusses TAAP and MPAR® Applications and OncoZenge Partnership with The Stock Day Podcast

DEC 11, 202312 MIN
Stock Day Media

Ensysce Biosciences Discusses TAAP and MPAR® Applications and OncoZenge Partnership with The Stock Day Podcast

DEC 11, 202312 MIN

Description

<div>The Stock Day Podcast welcomed Ensysce Biosciences (Nasdaq:ENSC)(“the Company”), a clinical-stage company using its proprietary technology platforms to develop safer prescription drugs. CEO of the Company, Dr. Lynn Kirkpatrick, joined Stock Day host Matthew Dunehoo. </div>